{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:59:10Z","timestamp":1793069950326,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejogrb.2023.12.035","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T10:33:03Z","timestamp":1703500383000},"page":"4-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0873-3925","authenticated-orcid":false,"given":"Alberto","family":"Vaiarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Cimadomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4301-2322","authenticated-orcid":false,"given":"Alessandro","family":"Ruffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Rania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pittana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Carmelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Trabucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rosaria Campitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rienzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Maria Ubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Venturella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.12.035_b0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/GCO.0000000000000452","article-title":"What is new in the management of poor ovarian response in IVF?","volume":"30","author":"Vaiarelli","year":"2018","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"Poseidon Group. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.rbmo.2020.01.027","article-title":"Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis","volume":"40","author":"Alexandru","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0020","article-title":"State of the art and emerging drug therapies for female infertility","volume":"1\u20137","author":"Venturella","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/09513590.2015.1081683","article-title":"Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response","volume":"32","author":"Li","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/cen.12983","article-title":"Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study","volume":"84","author":"Wang","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0045","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Begueria","year":"2019","journal-title":"Hum Reprod"},{"issue":"62\u201370","key":"10.1016\/j.ejogrb.2023.12.035_b0050","first-page":"e3","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","article-title":"New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology","volume":"298","author":"Iwami","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0065","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","article-title":"Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation","volume":"35","author":"La Marca","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.rbmo.2022.03.003","article-title":"Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol","volume":"45","author":"Yang","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40001-023-01000-1","article-title":"Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist\/antagonist protocol","volume":"28","author":"Wang","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmjsrh-2020-200619","article-title":"Norethisterone and its acetate - what's so special about them?","volume":"47","author":"Huvinen","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2023.12.035_b0085","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2011.04.009","article-title":"Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide","volume":"84","author":"Endrikat","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0095","unstructured":"Gardner DK, Schoolcraft B. In vitro culture of human blastocysts, Toward Reproductive Certainty: Fertility and Genetics Beyond. Parthenon Publishing London. 1999:378-88."},{"key":"10.1016\/j.ejogrb.2023.12.035_b0100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/humrep\/dez078","article-title":"Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing","volume":"34","author":"Cimadomo","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0110","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/humrep\/dez234","article-title":"The effect of ICSI-related procedural timings and operators on the outcome","volume":"35","author":"Maggiulli","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10815-018-1195-4","article-title":"Continuous embryo culture elicits higher blastulation but similar cumulative delivery rates than sequential: a large prospective study","author":"Cimadomo","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0125","doi-asserted-by":"crossref","DOI":"10.3791\/59625","article-title":"Human Blastocyst Biopsy and Vitrification","author":"Maggiulli","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/humrep\/deu033","article-title":"Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts","volume":"29","author":"Capalbo","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0135","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/humrep\/deu012","article-title":"ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010","volume":"29","author":"Moutou","year":"2014","journal-title":"Hum Reprod"},{"issue":"656\u201363","key":"10.1016\/j.ejogrb.2023.12.035_b0140","first-page":"e1","article-title":"The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/humupd\/dmx026","article-title":"Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging","volume":"23","author":"Capalbo","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0150","first-page":"139","article-title":"Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance","volume":"23","author":"Rienzi","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0155","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.ajhg.2021.11.002","article-title":"Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial","volume":"108","author":"Capalbo","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2020.03.005","article-title":"Incidence, Origin, and Predictive Model for the Detection and Clinical Management of Segmental Aneuploidies in Human Embryos","author":"Girardi","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0010-7824(95)00255-3","article-title":"Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions","volume":"53","author":"Heikinheimo","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11596-018-1908-z","article-title":"Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF\/ICSI Cycle: A Self-controlled Study","volume":"38","author":"Chen","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0175","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-019-0518-3","article-title":"Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study","volume":"17","author":"Peng","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF\/ICSI Cycle: A Randomized Clinical Trial","volume":"12","author":"Xi","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13063-018-2850-x","article-title":"Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial","volume":"19","author":"Wang","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jogoh.2018.10.008","article-title":"Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF\/ICSI compared to a GnRH antagonist protocol: A retrospective study","volume":"48","author":"Huang","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0200","first-page":"74","article-title":"The effects of progesterone on oocyte maturation and embryo development","volume":"7","author":"Salehnia","year":"2013","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0205","doi-asserted-by":"crossref","first-page":"e918705","DOI":"10.12659\/MSM.918705","article-title":"Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures","volume":"26","author":"Shen","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18502\/ijrm.v18i1.6197","article-title":"Effect of oral Utrogestan in comparison with Cetrotide on preventing luteinizing hormone surge in IVF cycles: A randomized controlled trial","volume":"18","author":"Ghasemzadeh","year":"2019","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.18502\/ijrm.v17i9.5103","article-title":"Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: An RCT","volume":"17","author":"Eftekhar","year":"2019","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0220","doi-asserted-by":"crossref","first-page":"e11906","DOI":"10.1097\/MD.0000000000011906","article-title":"Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0225","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2147\/DDDT.S210228","article-title":"Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rbmo.2021.09.022","article-title":"Inter-centre reliability in embryo grading across several IVF clinics is limited: implications for embryo selection","volume":"44","author":"Cimadomo","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0235","first-page":"CD002118","article-title":"Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology","author":"Glujovsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0240","doi-asserted-by":"crossref","first-page":"e0280238","DOI":"10.1371\/journal.pone.0280238","article-title":"Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study","volume":"18","author":"Filippi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.04.013","article-title":"Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy","volume":"47","author":"Giles","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2023.12.035_b0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial","volume":"116","author":"Giles","year":"2021","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523008850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523008850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:02:27Z","timestamp":1759557747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523008850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":50,"alternative-id":["S0301211523008850"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.12.035","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}